评估大麻使用与长度脏结果的关联
Flor Alvarado1, Dingfen Han2, Alan B Zonderman3
1Section of Nephrology and Hypertension, John W. Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Cannabis and cannabinoid research
|July 30, 2025
概括
这项研究没有发现经常使用大麻的成年人患慢性病 (CKD) 或相关结果的风险增加. 对大麻使用和脏健康的研究表明,随着时间的推移,没有任何不良关联.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 公共卫生 公共卫生
- 药物使用研究研究 药物使用研究
背景情况:
- 大麻是美国广泛使用的物质,需要对其健康影响进行研究.
- 以前的研究还没有完全阐明大麻使用对功能的长期影响.
研究的目的:
- 调查大麻使用模式与成年人队列中的纵向脏结果之间的关联.
- 为了确定经常食用大麻是否与慢性病 (CKD) 的风险增加,功能快速下降或白尿相关.
主要方法:
- 利用了来自美国巴尔的摩市"跨生命周期多样性社区健康老龄化" (HANDLS) 研究的数据.
- 根据基线大麻使用 (2004-2009) 和评估纵向脏结果 (2013-2017) 进行了分类参与者 (N=1,521).
- 采用多变量后勤回归,调整社会人口统计学,健康因素和并发性物质使用,以分析发生CKD,快速EGFR下降和发生白尿的风险.
主要成果:
- 目前的常规大麻使用者更有可能是年轻人,男性,黑人,并使用其他物质,如香烟,片或可卡因.
- 在调整了混因素后,当前定期使用大麻并没有与发生性CKD (OR:0.79),快速功能下降 (OR:0.80) 或发生性白蛋白尿症 (OR:0.84) 的更高风险相关.
结论:
- 在这组没有先前存在的CKD的成年人中,大麻使用与随着时间的推移与不良脏结果没有独立联系.
- 研究结果表明,在这个研究群体中,定期食用大麻不会对脏健康造成重大风险.
相关概念视频
01:29Acute Kidney Injury III: Clinical Manifestations
94
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94
02:20Longitudinal Research
12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
01:24Chronic Kidney Disease II: Clinical Manifestations
96
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
96
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:25Chronic Kidney Disease I: Introduction
73
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
73
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60